Skip to main navigation
Skip to search
Skip to main content
Northwestern Scholars Home
Help & FAQ
Home
Experts
Organizations
Research Output
Grants
Core Facilities
Research Data
Search by expertise, name or affiliation
Prot #BGB-11417-301: A Phase 3, Open-Label, Randomized Study of Sonrotoclax (BGB�11417) Plus Zanubrutinib (BGB-3111) Compared with Venetoclax Plus Obinutuzumab in Patients with Previously Untreated Chronic Lymphocytic Leukemia
Ma, Shuo
(PD/PI)
Medicine, Hematology Oncology Division
Project
:
Research project
Overview
Project Details
Status
Active
Effective start/end date
5/31/24
→
5/31/27
Funding
BeiGene USA, Inc.
(Prot #BGB-11417-301)
View all
View less